What is Transcatheter Aortic Valve Replacement (TAVR)?
Transcatheter Aortic Valve Replacement (TAVR) is a minimally invasive procedure
to replace the aortic valve in patients with severe aortic stenosis, a
narrowing of the aortic valve that restricts blood flow. Left untreated,
aortic stenosis can result in many symptoms and even death. This state-of-the-art
surgical procedure combines the expert skills of interventional cardiology
and cardiac surgery with advanced imaging technology to replace damaged
heart valves without opening the chest.
During the procedure, a tightly collapsed prosthetic valve is guided through
an artery, typically accessed via small incision in the patient’s
leg, to the heart. Once in place, the NEW valve is opened and the damaged
valve is pushed aside. Once open, the new valve begins working immediately.
The total surgery time is typically two hours or less and recovery generally
takes a few weeks.
To learn more about the procedure, watch the American Heart Association’s
Who is a good candidate for TAVR?
Currently, TAVR is the preferred treatment for patients with severe, symptomatic
aortic stenosis. The procedure is approved by the Food and Drug Administration
(FDA) for use in patients at intermediate or high risk of complications
from an open heart procedure. These patients are typically of advanced
age or have other medical conditions, such as severe lung disease or prior
open heart surgeries, which may interfere with recovery.
Patients with low risk of complications are still treated with open heart
surgery; however, due to its minimally invasive approach and outcomes,
TAVR is expected to be the standard approach for valve replacement for
all patients in the future.
Preparation and Recovery
The TAVR program at CaroMont Heart & Vascular is comprised of a multi-disciplinary
team of expert interventional cardiologists, surgeons, anesthesiologists
and imagingclinicians. Patients can expect an in-depth assessment by the
cardiac team to determine the severity of their aortic stenosis and eligibility
for TAVR. Each week, the team evaluates cases that may benefit from the
procedure, ensuring several structural cardiology experts review each
patient’s treatment plan.
After surgery, patients are admitted to CaroMont Regional Medical Center
for monitoring. Most patients spend two days in the hospital and then
return for regular, in-office follow-up at CaroMont Heart & Vascular.
Meet Our Team
The TAVR program at CaroMont Regional Medical Center is an extension of
the many services provided by CaroMont Heart & Vascular. This cutting-edge
procedure relies on a highly trained and skilled surgical team comprised
of highly experienced, skilled physicians including Interventional Cardiologists,
Dr. Amish Sura and Dr. Harpreet Bhalla, and cardiac surgeon Dr. James
Greelish, as well as Cardiac Anesthesiologists.
The cardiovascular team at CaroMont Heart & Vascular has a strong team
approach to caring for patients. That is particularly evident with the
TAVR procedure because it requires a significant level of skill and collaboration
not only with the doctors, but also with the entire surgical team. This
level of expertise places the program among the top cardiovascular teams
in the state, and the commitment to collaboration means that patients
are always put first.
Dr. Greelish and
Dr. Sura and the many talented experts at
CaroMont Heart & Vascular.